Dr. Dean Felsher is a Professor in the Division of Oncology, Departments of Medicine and Pathology at Stanford University School of Medicine. He is currently the Founding Director of the Translational and Applied Medicine Program, Director of Oncology Research, Director of Medical Scientist Training Program Admissions, Director of Advanced Residency Training Program and the co-Director of the Cancer Translational Nanotechnology Training Program. He received his BA from the University of Chicago and his MD and PhD from the UCLA Medical Scientist Training Program. He did a residency in internal medicine at the University of Pennsylvania and a fellowship in Medical Oncology at UCSF. He joined the faculty at Stanford in 1999. He has over 20 years of research experience working with experimental transgenic mouse models and has pioneered the utilization of the Tet System to generate conditional transgenic mouse models of lymphoma, hepatocellular adenocarcinoma, osteogenic sarcoma, kidney adenocarcinoma and lung adenocarcinoma. He has a mentored to date over 80 members in his laboratory many of whom are now independent scientists in Academia and Industry. His laboratory currently consists of 20 research associates, post-doctoral fellows, medical, college and graduate students. Dr. Felsher’s work has helped to establish the general concepts of the reversibility of cancer, oncogene addiction, tumor dormancy. His work has been published and highlighted in articles in Science, Journal of Clinical Investigation and Nature. He has published over 150 papers, given more than 260 invited talks. He is a Senior Editor of Cancer Research and Oncogene.